Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $8.5450, but opened at $9.43. Ambu A/S shares last traded at $9.43, with a volume of 750 shares traded.
Ambu A/S Trading Up 10.4%
The firm’s 50 day simple moving average is $10.09 and its two-hundred day simple moving average is $11.70. The company has a quick ratio of 1.73, a current ratio of 2.92 and a debt-to-equity ratio of 0.08. The stock has a market cap of $2.22 billion, a P/E ratio of 33.68 and a beta of 0.98.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 EPS for the quarter. The business had revenue of $246.39 million during the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.03%.
Ambu A/S Company Profile
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
See Also
- Five stocks we like better than Ambu A/S
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
